Company Highlights Proprietary, Industry-First Imaging Technology Targeting the Multibillion Dollar Global Healthcare Market in Latest Video
Guardian Technologies International (OTCBB: GDTI), innovators of groundbreaking medical imaging and threat detection technology with critical and immediate applications for the healthcare and homeland security markets, today released a new investor video detailing the Company’s groundbreaking disease-detection Signature Mapping product targeting the multibillion dollar global healthcare market.
“Our Signature Mapping medical technology could well be the latest breakthrough in digital imaging system technology,” said Richard Borelli in the new video. Mr. Borelli is Vice President of Healthcare Systems at Guardian Technologies. “The significant revenues we intend to generate from this and our next-generation radiology and detection technologies will be of keen interest to investors.”
Signature Mapping is an advanced analysis and visualization technology that can be seamlessly installed to read images from any medical imaging device, including MRIs, CT-scans and x-rays, to detect disease states in the brain, lungs, heart and prostate. It can even visualize difficult-to-distinguish breast cancer in dense breast tissue that might otherwise have gone undetected.
“Current imaging visualization and detection technologies rely on basic pattern recognition,” said Mr. Borelli. “Signature Mapping pushes well beyond that, utilizing unique scripts and algorithms to visualize and extract subtle energy signatures within tissues to clarify and identify normal from diseased areas.”
Guardian recently acquired exclusive rights to iC Works software technology from Virginia-based Zinon Company, in a move that is expected to accelerate the Company’s planned FDA clinical trials, potentially advancing by as much as one year federal approval for a broad range of health care applications.
Protected by a robust patent portfolio, Guardian’s technology can be added to existing imaging devices and significantly enhances images to quickly and accurately identify a myriad of threats, be they medical or terrorist related. Guardian is committed to aggressively marketing its first to market digital imaging solutions to both the healthcare and Homeland security sectors.
To view the entire video presentation, please visit: http://www.trilogy-capital.com/tcp/guardian.
About Guardian Technologies International
The impact of Guardian's industry-first computer aided detection technologies are immediate and profound for helping to eliminate human error in both the Homeland Security and the Medical Industry sectors. The Company's software solutions can be seamlessly installed to complement existing imaging devices, such as baggage scanners and medical MRI, to scan the contents of any image and immediately identify items of interest not easily discernable by the human eye.
- Airport Security: Guardian's technology complements and enhances current-generation baggage x-ray scanners with the ability to automatically and effectively detect, locate, and identify explosives and other types of threats.
- Disease Identification: Existing medical imaging devices used in Computer Aided Detection (CAD) are further improved with Guardian's auto-diagnostic ability to detect anomalous tissue (e.g., tumors) and other potential disease states or conditions.
- Technology-Independence: Because Guardian's technologies utilize and process the actual image output generated by the original imaging systems, virtually any existing or future imaging device can be upgraded with Guardian's products, delivering an instant, multibillion-dollar potential customer base with no competition.
Guardian's technology and product development partnerships include a Cooperative Research and Development Agreement (CRDA) with the U.S. Department of Homeland Security - Science and Technology Directorate. The Company's platform and product suite is protected by a robust patent portfolio. They are also ramping up new technologies and plan to acquire complimentary technologies to accelerate the Company's high-growth business model.
For investor-specific information and resources, visit http://www.trilogy-capital.com/tcp/guardian.
To view current stock quotes and news, visit http://www.trilogy-capital.com/tcp/guardian/quote.html.
To view an investor fact sheet about the company, visit http://www.trilogy-capital.com/tcp/guardian/factsheet.html.
Forward-Looking Statements
This news release contains forward-looking statements that involve risks and uncertainties. Forward-looking statements in this document and those made from time to time by Guardian through its senior management are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect the Company's current views with respect to the future events or financial performance discussed in this release, based on management's beliefs and assumptions and information currently available. When used, the words "believe," "anticipate," "estimate," "project," "should," "expect," "plan," "assume" and similar expressions that do not relate solely to historical matters identify forward-looking statements. Forward-looking statements concerning future plans or results are necessarily only estimates and actual results could differ materially from expectations. Certain factors that could cause or contribute to such differences include, among other things, in particular, the size and timing of contract awards, performance on contracts, performance of acquired companies, availability and cost of key components, unanticipated results from audits of the financial results of the Company and acquired companies, changing interpretations of generally accepted accounting principles, outcomes of government reviews, developments with respect to litigation to which we are a party, potential fluctuations in quarterly results, dependence on large contracts and a limited number of customers, lengthy sales and implementation cycles, market acceptance of new or enhanced products and services, proprietary technology and changing competitive conditions, system performance, management of growth, dependence on key personnel, ability to obtain project financing, general economic and political conditions and other factors affecting spending by customers, the unpredictable nature of working with government agencies and other risks, uncertainties and factors including those described from time to time in Guardian's filings with the Securities and Exchange Commission, including without limitation, Guardian's Form 10-K for the year ended December 31, 2006, and its quarterly reports on Form 10-Q. Guardian expressly disclaims any obligation to update any forward-looking statements.
Guardian Technologies International, Inc.
Michael Trudnak, 703-464-5495
info@guardiantechintl.com
or
Financial Communications
Trilogy Capital Partners
Ryon Harms, 800-592-6067
ryon@trilogy-capital.com